Becton Dickinson Launches Innovative Elyra™ Thulium Fiber Laser System for Urologic Care

- Becton Dickinson launched the Elyra™ Thulium Fiber Laser System, enhancing capabilities in managing kidney stones and soft tissue procedures.
- The Elyra™ TFL System features an air-cooled design, intuitive interface, and customizable options for improved clinical efficiency.
- BD's commitment to innovation in urologic care is demonstrated by the Elyra™ TFL System and expanded infection prevention initiatives.
Becton, Dickinson and Company (BDX) capitalizes on innovation in urologic care with the launch of its new Elyra™ Thulium Fiber Laser (TFL) System. This cutting-edge technology is specifically tailored for managing kidney stones and conducting soft tissue procedures, marking a significant advancement in the company’s medical product portfolio. Designed to enhance procedural efficiency and versatility for urologic teams, the Elyra™ TFL System leverages Thulium Fiber Laser technology, significantly improving stone dusting capabilities and reducing the risk of stone migration during procedures. This innovative approach showcases BD's commitment to elevating the standard of care in urology, while also addressing the intricate challenges faced in current clinical practices.
The Elyra™ TFL System stands out with its air-cooled design that reduces noise, making it an operator-friendly choice in clinical settings. It is available in two configurations—Elyra™ and Elyra™ Plus—allowing healthcare facilities to select the option that best fits their operational needs. Its features include an intuitive user interface, quick-start capabilities, customizable presets, and an optional wireless footswitch to streamline workflows. As stated by Mike Cusack, worldwide president of Urology and Critical Care at BD, this system is a testament to BD's dedication to delivering high-quality, innovative solutions that enhance clinical outcomes for patients.
Following positive feedback from initial clinical cases at a leading medical center, the Elyra™ TFL System is now available in the U.S., further solidifying BD's position in the urologic care market. This strategic expansion complements their comprehensive portfolio of solutions for stone management, which includes access, dilation, visualization, fragmentation, removal, and drainage technologies. As BD continues to innovate and optimize performance in urologic care, the healthcare community can anticipate more robust offerings that prioritize patient safety and procedure efficiency.
In addition to launching the Elyra™ TFL System, BD is navigating leadership changes with the appointment of Peter Menziuso as the Executive Vice President and President of BD Interventional. He is set to assume his role on June 1, 2026, bringing over 30 years of healthcare leadership experience to the company. Moreover, BD has expanded its partnership with Bactiguard to focus on infection prevention, specifically developing coated Foley catheters, indicating the company’s ongoing commitment to enhancing patient care across its diverse product lines.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

